Sagimet Biosciences (SGMT) Superinvestor holders
7 of the superinvestors we track hold Sagimet Biosciences (SGMT) in their latest 13F filings, $14M in total.
Summary
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $6M, 0.7% of the portfolio.
In their latest quarter: 2 opened a new position, 1 added, 3 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Zhang Lei Hillhouse (HHLR Advisors) |
Held | 724,800 | $6M | 0.7% | Q2 2026 |
| Tom Steyer Farallon Capital Management LLC |
New position | 415,000 | $3M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 346,927 | $3M | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
New position | 186,004 | $2M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 81,902 | $633,102 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 22,177 | $171,428 | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 13,856 | $107,107 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 6 |
| Q1 2026 | 9 |
| Q4 2025 | 8 |
| Q3 2025 | 6 |
| Q2 2025 | 4 |
| Q1 2025 | 4 |
| Q4 2024 | 6 |
| Q3 2024 | 7 |
Questions about Sagimet Biosciences
Which superinvestors own Sagimet Biosciences?
7 of the superinvestors we track hold Sagimet Biosciences (SGMT) in their latest 13F filings, $14M in total. Zhang Lei, Tom Steyer, Jim Simons, Acadian, Two Sigma, David Shaw.
Who is the largest superinvestor holder of SGMT?
The largest holder is Zhang Lei (Hillhouse (HHLR Advisors)), with $6M, 0.7% of the portfolio.
From Sagimet Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.